Interleukin-17–Dependent Autoimmunity to Collagen Type V in Atherosclerosis
Author(s) -
Melanie L. Dart,
Ewa Jankowska−Gan,
Guorui Huang,
Drew A. Roenneburg,
Melissa R. Keller,
José Torrealba,
Aaron Rhoads,
Byoungjae Kim,
Joseph L. Bobadilla,
Lynn D. Haynes,
David S. Wilkes,
William J. Burlingham,
Daniel S. Greenspan
Publication year - 2010
Publication title -
circulation research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.899
H-Index - 336
eISSN - 1524-4571
pISSN - 0009-7330
DOI - 10.1161/circresaha.110.221069
Subject(s) - autoimmunity , pathogenesis , immunology , apolipoprotein e , immunity , inflammation , immune system , medicine , biology , disease , pathology
Considerable evidence shows atherosclerosis to be a chronic inflammatory disease in which immunity to self-antigens contributes to disease progression. We recently identified the collagen type V [col(V)] α1(V) chain as a key autoantigen driving the Th17-dependent cellular immunity underlying another chronic inflammatory disease, obliterative bronchiolitis. Because specific induction of α1(V) chains has previously been reported in human atheromas, we postulated involvement of col(V) autoimmunity in atherosclerosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom